Influence of Region‐Specific Alterations of Neuropeptidase Content on the Catabolic Fates of Neuropeptides in Alzheimer's Disease
Carole Ichai(Société Française d'Allergologie), Frédéric Checler(Centre National de la Recherche Scientifique), Pascal Dournaud(Délégation Paris 7), Jean‐Pierre Vincent(Institut de Pharmacologie Moléculaire et Cellulaire), Jacques Epelbaum(Centre National de la Recherche Scientifique), Nathalie Chevallier(University of California, San Diego), Jean‐Jacques Hauw(Sorbonne Université), P. Delaère(Pitié-Salpêtrière Hospital)
Cited by 51
Related Papers
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
|Nature Genetics|2017|1.1k
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
|Molecular Psychiatry|2013|440
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
The role of JAK-STAT signaling within the CNS
|JAK-STAT|2013|352